Literature DB >> 25996386

Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Marco Antonio Bonini Filho1, Talisa E de Carlo2, Daniela Ferrara3, Mehreen Adhi3, Caroline R Baumal3, Andre J Witkin3, Elias Reichel3, Jay S Duker3, Nadia K Waheed3.   

Abstract

IMPORTANCE: Choroidal neovascularization (CNV) is a major cause of vision loss in chronic central serous chorioretinopathy (CSCR). Detecting CNV using fluorescein angiography (FA) may be challenging owing to the coexistence of features related to the primary diagnosis of CSCR. Optical coherence tomography angiography (OCTA) allows noninvasive visualization of retinal and choroidal vasculature via motion contrast and may contribute to the unequivocal diagnosis of CNV in this population.
OBJECTIVE: To evaluate the sensitivity of spectral-domain OCTA in detecting CNV associated with chronic CSCR. DESIGN, SETTING, AND PARTICIPANTS: Observational cross-sectional study including 23 patients (27 eyes) who presented at the New England Eye Center between August 1, 2014, and November 30, 2014, with suspected CNV complicating chronic CSCR and underwent standard assessment for CNV diagnosis, including FA imaging. Participants were prospectively recruited to receive imaging tests using prototype OCTA software on a commercially available spectral-domain OCT. Orthogonal registration and the merging of 2 consecutive image sets were used to obtain 3 × 3-mm and 6 × 6-mm OCT angiograms centered at the macula. Two independent readers masked to other imaging findings performed a qualitative analysis on OCTA depictions of vascular flow representing CNV and the morphologic appearance of CNV. MAIN OUTCOMES AND MEASURES: Choroidal neovascularization location as well as retinal pigment epithelial detachment internal reflectivity and the presence of subretinal and intraretinal fluid. Sensitivity and specificity of OCTA in detecting CNV were estimated using FA as the standard examination reference.
RESULTS: Choroidal neovascularization was diagnosed in 8 of 27 eyes (30%) based on FA imaging analysis. Optical coherence tomography angiography and corresponding OCT B-scans detected 100% (8 of 8) of these CNV lesions and correctly excluded 100% (19 of 19) of eyes with CSCR without CNV. Sensitivity was 100% (95% CI, 0.62-1) and specificity was 100% (95% CI, 0.82-1). Morphologic appearance, location, and position of the CNV relative to the retinal pigment epithelium and Bruch membrane were described using OCTA that combined flow and structural information. CONCLUSIONS AND RELEVANCE: This study suggests that OCT alone (OCTA and coregistered OCT B-scans) features sensitivity and specificity comparable with FA for the detection of CNV in eyes with chronic CSCR.

Entities:  

Mesh:

Year:  2015        PMID: 25996386      PMCID: PMC4721607          DOI: 10.1001/jamaophthalmol.2015.1320

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  22 in total

1.  Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.

Authors:  Roy H Loo; Ingrid U Scott; Harry W Flynn; J Donald M Gass; Timothy G Murray; Mary Lou Lewis; Phillip J Rosenfeld; William E Smiddy
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

2.  Measurement of blood flow velocity in feeder vessels of choroidal neovascularization by a scanning laser ophthalmoscope and image analysis system.

Authors:  Yoshihiro Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 2.447

3.  Photocoagulation treatment of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 May-Jun

4.  Choroidal neovascularization and central serous chorioretinopathy.

Authors:  J E Gomolin
Journal:  Can J Ophthalmol       Date:  1989-02       Impact factor: 1.882

5.  Indocyanine green videoangiography of older patients with central serous chorioretinopathy.

Authors:  R F Spaide; L Hall; A Haas; L Campeas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Retina       Date:  1996       Impact factor: 4.256

6.  Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

Authors:  U E Schnurrbusch; K Welt; L C Horn; P Wiedemann; S Wolf
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

7.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

8.  Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy.

Authors:  L A Yannuzzi; J L Shakin; Y L Fisher; M A Altomonte
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  [Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy].

Authors:  H Matsunaga; K Nangoh; M Uyama; H Nanbu; Y Fujiseki; K Takahashi
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1995-04

10.  Cystoid macular degeneration in chronic central serous chorioretinopathy.

Authors:  Tomohiro Iida; Lawrence A Yannuzzi; Richard F Spaide; Natalie Borodoker; Cynthia A Carvalho; Silvana Negrao
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

View more
  64 in total

1.  [Fluorescein, indocyanine green and optical coherence tomography angiography in patients with native exudative age-related macular degeneration].

Authors:  L J B Pauleikhoff; K Blobner; K Wehrmann; N Feucht; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

2.  Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.

Authors:  Vladimir Sheptulin; Konstantine Purtskhvanidze; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-10       Impact factor: 3.117

Review 3.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

4.  Analyzing Relative Blood Flow Speeds in Choroidal Neovascularization Using Variable Interscan Time Analysis OCT Angiography.

Authors:  Carl B Rebhun; Eric M Moult; Stefan B Ploner; Carlos Moreira Neto; A Yasin Alibhai; Julia Schottenhamml; Byungkun Lee; WooJhon Choi; Fareed A Rifai; Mary W Tam; Lennart Husvogt; Caroline R Baumal; Andre J Witkin; Andreas Maier; Philip J Rosenfeld; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Ophthalmol Retina       Date:  2017-10-31

5.  The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography.

Authors:  Francesco Pichi; Mariachiara Morara; Chiara Veronese; Antonio P Ciardella
Journal:  Int Ophthalmol       Date:  2017-05-11       Impact factor: 2.031

Review 6.  Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.

Authors:  Francesco Sartini; Michele Figus; Giamberto Casini; Marco Nardi; Chiara Posarelli
Journal:  Int Ophthalmol       Date:  2020-07-30       Impact factor: 2.031

7.  Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  Sibel Demirel; Gökçen Özcan; Özge Yanık; Figen Batıoğlu; Emin Özmert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

8.  [Uniform classification of the pachychoroid spectrum disorders].

Authors:  Alaa Din Abdin; Shady Suffo; Fabian N Fries; Hakan Kaymak; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-04-26       Impact factor: 1.059

9.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

10.  The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography.

Authors:  Sibel Demirel; Özge Yanık; Hilal Nalcı; Figen Batıoğlu; Emin Özmert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.